Delivery Order SPE2DR25D1007-SPE2DR26FY8BF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 8, 2025, with a completion date of August 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.65 to AmerisourceBergen Drug Corp for the provision of Varivax vaccine with diluents. The contract, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 14, 2025. This competitive award, issued on September 22, 2025, utilizes firm fixed price terms and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Varivax vaccine with diluents, valued at $1,053.01. The contract is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,846.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This...
- SPE2DR25D1007Indefinite Delivery Contract
- SPE2DR25D1007-SPE2DR26FY8BFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.65 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on November 3, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply vaccines, medications, medical devices, and other healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Varivax vaccine procurement aligns with the DLA's medical supply chain mission to provide critical pharmaceutical products to military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/3/25 |